Katrina Cathie - Publications

Safety and immunogenicity of concomitant quadrivalent meningococcus ACYW-TT and meningococcus group B vaccines.

Journal: NPJ vaccines

Published: February 19, 2026

Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trial.

Journal: The Lancet. Infectious diseases

Published: October 06, 2025

Quality of Life Impact of Varicella on Children and Their Families in the UK: The QoLPoX Study.

Journal: The Pediatric infectious disease journal

Published: September 19, 2025

Protocol for a Group-Sequential Two-Stratum Multicenter Open-Label Randomized Clinical Trial of Respiratory Support in Infants With Acute Bronchiolitis: Breathing Assistance in Children With Bronchiolitis (BACHb).

Journal: Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies

Published: August 14, 2025

Reactogenicity and immunogenicity following heterologous and homologous third dose COVID-19 vaccination in UK adolescents (Com-COV3): A randomised controlled non-inferiority trial.

Journal: The Journal of infection

Published: May 27, 2025

Effectiveness of biomarker-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection: the BATCH RCT.

Journal: Health technology assessment (Winchester, England)

Published: May 19, 2025

Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: Results from COV-BOOST trial.

Journal: The Journal of infection

Published: March 11, 2025

Protecting Against Respiratory Syncytial Virus: An Online Questionnaire Study Exploring UK Parents' Acceptability of Vaccination in Pregnancy or Monoclonal Antibody Administration for Infants.

Journal: The Pediatric infectious disease journal

Published: February 14, 2025

180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trial.

Journal: The Lancet. Child & adolescent health

Published: October 21, 2024

Procalcitonin-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection in the UK (BATCH): a pragmatic, multicentre, open-label, two-arm, individually randomised, controlled trial.

Journal: The Lancet. Child & adolescent health

Published: August 08, 2024

International Networks for Pediatric Inpatient Research and Excellence (INSPIRE): A global initiative in pediatric hospital medicine.

Journal: Journal of hospital medicine

Published: July 22, 2024

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants.

Journal: The New England journal of medicine

Published: December 29, 2023